11 家研究公司对 Shockwave Medical 的评级为平均“持有”。 11 research firms rate Shockwave Medical at an average "Hold".

11 家研究公司对 Shockwave Medical (NASDAQ:SWAV) 给出了平均“持有”评级，一致目标价为 309.11 美元。 11 research firms covering Shockwave Medical (NASDAQ:SWAV) have given an average recommendation of "Hold", with a $309.11 consensus target price. 最近的研究报告包括 Needham & Company LLC 的“持有”评级、Leerink Partners 的评级下调至“市场表现”，以及 Canaccord Genuity Group 的“持有”评级和 335.00 美元的目标价。 Recent research reports include Needham & Company LLC's "hold" rating, Leerink Partners' downgrade to "market perform", and Canaccord Genuity Group's "hold" rating with a $335.00 target price. 该公司的贝塔系数为 0.88，表明股价波动性比标准普尔 500 指数低 12%。 The company has a beta of 0.88, indicating 12% less share price volatility than the S&P 500.